 | • レポートコード：MRC308GR09500 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の小児乾癬治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の小児乾癬治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 小児乾癬治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
小児乾癬治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・局所治療、全身治療
用途別セグメント
・尋常性乾癬、膿疱性乾癬、紅皮症性乾癬、関節症性乾癬
主要な市場プレーヤー
・AbbVie、Amgen、Johnson and Johnson、Novartis AG、Eli Lilly and Company、AstraZeneca、Celgene Corporation、UCB、Merck、Boehringer Ingelheim、LEO Pharma、Qingdao Vland Biotech、Yunnan Botanee Bio-Technology、Furen Group、Jiangsu Kanion Pharmaceutical、Tianjin Pacific Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、小児乾癬治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な小児乾癬治療メーカーの企業概要、2019年～2022年までの小児乾癬治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な小児乾癬治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別小児乾癬治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの小児乾癬治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での小児乾癬治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および小児乾癬治療の産業チェーンを掲載しています。
・第14、15章では、小児乾癬治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 小児乾癬治療の概要
– 種類別分析（2018年vs2022年vs2029年）：局所治療、全身治療
– 用途別分析（2018年vs2022年vs2029年）：尋常性乾癬、膿疱性乾癬、紅皮症性乾癬、関節症性乾癬
– 世界の小児乾癬治療市場規模・予測
– 世界の小児乾癬治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– AbbVie、Amgen、Johnson and Johnson、Novartis AG、Eli Lilly and Company、AstraZeneca、Celgene Corporation、UCB、Merck、Boehringer Ingelheim、LEO Pharma、Qingdao Vland Biotech、Yunnan Botanee Bio-Technology、Furen Group、Jiangsu Kanion Pharmaceutical、Tianjin Pacific Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：局所治療、全身治療
・用途別分析2018年-2029年：尋常性乾癬、膿疱性乾癬、紅皮症性乾癬、関節症性乾癬
・小児乾癬治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・小児乾癬治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・小児乾癬治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・小児乾癬治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・小児乾癬治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Pediatric Psoriasis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pediatric Psoriasis Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Topical Treatment
1.3.3 Systemic Treatment
1.4 Market Analysis by Application
1.4.1 Overview: Global Pediatric Psoriasis Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Psoriasis Vulgaris
1.4.3 Pustular Psoriasis
1.4.4 Erythrodermic Psoriasis
1.4.5 Arthropathic Psoriasis
1.5 Global Pediatric Psoriasis Treatment Market Size & Forecast
1.5.1 Global Pediatric Psoriasis Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pediatric Psoriasis Treatment Sales Quantity (2018-2029)
1.5.3 Global Pediatric Psoriasis Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Pediatric Psoriasis Treatment Product and Services
2.1.4 AbbVie Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Pediatric Psoriasis Treatment Product and Services
2.2.4 Amgen Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 Johnson and Johnson
2.3.1 Johnson and Johnson Details
2.3.2 Johnson and Johnson Major Business
2.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
2.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson and Johnson Recent Developments/Updates
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Pediatric Psoriasis Treatment Product and Services
2.4.4 Novartis AG Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis AG Recent Developments/Updates
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
2.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly and Company Recent Developments/Updates
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Pediatric Psoriasis Treatment Product and Services
2.6.4 AstraZeneca Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AstraZeneca Recent Developments/Updates
2.7 Celgene Corporation
2.7.1 Celgene Corporation Details
2.7.2 Celgene Corporation Major Business
2.7.3 Celgene Corporation Pediatric Psoriasis Treatment Product and Services
2.7.4 Celgene Corporation Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Celgene Corporation Recent Developments/Updates
2.8 UCB
2.8.1 UCB Details
2.8.2 UCB Major Business
2.8.3 UCB Pediatric Psoriasis Treatment Product and Services
2.8.4 UCB Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 UCB Recent Developments/Updates
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Pediatric Psoriasis Treatment Product and Services
2.9.4 Merck Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments/Updates
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business
2.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
2.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Boehringer Ingelheim Recent Developments/Updates
2.11 LEO Pharma
2.11.1 LEO Pharma Details
2.11.2 LEO Pharma Major Business
2.11.3 LEO Pharma Pediatric Psoriasis Treatment Product and Services
2.11.4 LEO Pharma Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 LEO Pharma Recent Developments/Updates
2.12 Qingdao Vland Biotech
2.12.1 Qingdao Vland Biotech Details
2.12.2 Qingdao Vland Biotech Major Business
2.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
2.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Qingdao Vland Biotech Recent Developments/Updates
2.13 Yunnan Botanee Bio-Technology
2.13.1 Yunnan Botanee Bio-Technology Details
2.13.2 Yunnan Botanee Bio-Technology Major Business
2.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
2.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
2.14 Furen Group
2.14.1 Furen Group Details
2.14.2 Furen Group Major Business
2.14.3 Furen Group Pediatric Psoriasis Treatment Product and Services
2.14.4 Furen Group Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Furen Group Recent Developments/Updates
2.15 Jiangsu Kanion Pharmaceutical
2.15.1 Jiangsu Kanion Pharmaceutical Details
2.15.2 Jiangsu Kanion Pharmaceutical Major Business
2.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
2.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
2.16 Tianjin Pacific Pharmaceutical
2.16.1 Tianjin Pacific Pharmaceutical Details
2.16.2 Tianjin Pacific Pharmaceutical Major Business
2.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
2.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Pediatric Psoriasis Treatment by Manufacturer
3.1 Global Pediatric Psoriasis Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pediatric Psoriasis Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pediatric Psoriasis Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pediatric Psoriasis Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Pediatric Psoriasis Treatment Manufacturer Market Share in 2022
3.5 Pediatric Psoriasis Treatment Market: Overall Company Footprint Analysis
3.5.1 Pediatric Psoriasis Treatment Market: Region Footprint
3.5.2 Pediatric Psoriasis Treatment Market: Company Product Type Footprint
3.5.3 Pediatric Psoriasis Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pediatric Psoriasis Treatment Market Size by Region
4.1.1 Global Pediatric Psoriasis Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Pediatric Psoriasis Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Pediatric Psoriasis Treatment Average Price by Region (2018-2029)
4.2 North America Pediatric Psoriasis Treatment Consumption Value (2018-2029)
4.3 Europe Pediatric Psoriasis Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Pediatric Psoriasis Treatment Consumption Value (2018-2029)
4.5 South America Pediatric Psoriasis Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Pediatric Psoriasis Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
5.2 Global Pediatric Psoriasis Treatment Consumption Value by Type (2018-2029)
5.3 Global Pediatric Psoriasis Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
6.2 Global Pediatric Psoriasis Treatment Consumption Value by Application (2018-2029)
6.3 Global Pediatric Psoriasis Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
7.2 North America Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
7.3 North America Pediatric Psoriasis Treatment Market Size by Country
7.3.1 North America Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Pediatric Psoriasis Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Pediatric Psoriasis Treatment Market Size by Country
8.3.1 Europe Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Pediatric Psoriasis Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pediatric Psoriasis Treatment Market Size by Region
9.3.1 Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pediatric Psoriasis Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
10.2 South America Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
10.3 South America Pediatric Psoriasis Treatment Market Size by Country
10.3.1 South America Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Pediatric Psoriasis Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pediatric Psoriasis Treatment Market Size by Country
11.3.1 Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pediatric Psoriasis Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pediatric Psoriasis Treatment Market Drivers
12.2 Pediatric Psoriasis Treatment Market Restraints
12.3 Pediatric Psoriasis Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pediatric Psoriasis Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pediatric Psoriasis Treatment
13.3 Pediatric Psoriasis Treatment Production Process
13.4 Pediatric Psoriasis Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pediatric Psoriasis Treatment Typical Distributors
14.3 Pediatric Psoriasis Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Pediatric Psoriasis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pediatric Psoriasis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Pediatric Psoriasis Treatment Product and Services
Table 6. AbbVie Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. AbbVie Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Pediatric Psoriasis Treatment Product and Services
Table 11. Amgen Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson and Johnson Major Business
Table 15. Johnson and Johnson Pediatric Psoriasis Treatment Product and Services
Table 16. Johnson and Johnson Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson and Johnson Recent Developments/Updates
Table 18. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 19. Novartis AG Major Business
Table 20. Novartis AG Pediatric Psoriasis Treatment Product and Services
Table 21. Novartis AG Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis AG Recent Developments/Updates
Table 23. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly and Company Major Business
Table 25. Eli Lilly and Company Pediatric Psoriasis Treatment Product and Services
Table 26. Eli Lilly and Company Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly and Company Recent Developments/Updates
Table 28. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 29. AstraZeneca Major Business
Table 30. AstraZeneca Pediatric Psoriasis Treatment Product and Services
Table 31. AstraZeneca Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AstraZeneca Recent Developments/Updates
Table 33. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 34. Celgene Corporation Major Business
Table 35. Celgene Corporation Pediatric Psoriasis Treatment Product and Services
Table 36. Celgene Corporation Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Celgene Corporation Recent Developments/Updates
Table 38. UCB Basic Information, Manufacturing Base and Competitors
Table 39. UCB Major Business
Table 40. UCB Pediatric Psoriasis Treatment Product and Services
Table 41. UCB Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. UCB Recent Developments/Updates
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Pediatric Psoriasis Treatment Product and Services
Table 46. Merck Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Merck Recent Developments/Updates
Table 48. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 49. Boehringer Ingelheim Major Business
Table 50. Boehringer Ingelheim Pediatric Psoriasis Treatment Product and Services
Table 51. Boehringer Ingelheim Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Boehringer Ingelheim Recent Developments/Updates
Table 53. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 54. LEO Pharma Major Business
Table 55. LEO Pharma Pediatric Psoriasis Treatment Product and Services
Table 56. LEO Pharma Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. LEO Pharma Recent Developments/Updates
Table 58. Qingdao Vland Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Qingdao Vland Biotech Major Business
Table 60. Qingdao Vland Biotech Pediatric Psoriasis Treatment Product and Services
Table 61. Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Qingdao Vland Biotech Recent Developments/Updates
Table 63. Yunnan Botanee Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 64. Yunnan Botanee Bio-Technology Major Business
Table 65. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product and Services
Table 66. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Yunnan Botanee Bio-Technology Recent Developments/Updates
Table 68. Furen Group Basic Information, Manufacturing Base and Competitors
Table 69. Furen Group Major Business
Table 70. Furen Group Pediatric Psoriasis Treatment Product and Services
Table 71. Furen Group Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Furen Group Recent Developments/Updates
Table 73. Jiangsu Kanion Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Kanion Pharmaceutical Major Business
Table 75. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 76. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 78. Tianjin Pacific Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Tianjin Pacific Pharmaceutical Major Business
Table 80. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product and Services
Table 81. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Tianjin Pacific Pharmaceutical Recent Developments/Updates
Table 83. Global Pediatric Psoriasis Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Pediatric Psoriasis Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Pediatric Psoriasis Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Pediatric Psoriasis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Pediatric Psoriasis Treatment Production Site of Key Manufacturer
Table 88. Pediatric Psoriasis Treatment Market: Company Product Type Footprint
Table 89. Pediatric Psoriasis Treatment Market: Company Product Application Footprint
Table 90. Pediatric Psoriasis Treatment New Market Entrants and Barriers to Market Entry
Table 91. Pediatric Psoriasis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Pediatric Psoriasis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Pediatric Psoriasis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Pediatric Psoriasis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Pediatric Psoriasis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Pediatric Psoriasis Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Pediatric Psoriasis Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Pediatric Psoriasis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Pediatric Psoriasis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Pediatric Psoriasis Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Pediatric Psoriasis Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Pediatric Psoriasis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Pediatric Psoriasis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Pediatric Psoriasis Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Pediatric Psoriasis Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Pediatric Psoriasis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Pediatric Psoriasis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Pediatric Psoriasis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Pediatric Psoriasis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Pediatric Psoriasis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Pediatric Psoriasis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Pediatric Psoriasis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Pediatric Psoriasis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Pediatric Psoriasis Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Pediatric Psoriasis Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Pediatric Psoriasis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Pediatric Psoriasis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Pediatric Psoriasis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Pediatric Psoriasis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Pediatric Psoriasis Treatment Raw Material
Table 151. Key Manufacturers of Pediatric Psoriasis Treatment Raw Materials
Table 152. Pediatric Psoriasis Treatment Typical Distributors
Table 153. Pediatric Psoriasis Treatment Typical Customers
List of Figures
Figure 1. Pediatric Psoriasis Treatment Picture
Figure 2. Global Pediatric Psoriasis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Topical Treatment Examples
Figure 5. Systemic Treatment Examples
Figure 6. Global Pediatric Psoriasis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Application in 2022
Figure 8. Psoriasis Vulgaris Examples
Figure 9. Pustular Psoriasis Examples
Figure 10. Erythrodermic Psoriasis Examples
Figure 11. Arthropathic Psoriasis Examples
Figure 12. Global Pediatric Psoriasis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Pediatric Psoriasis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Pediatric Psoriasis Treatment Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Pediatric Psoriasis Treatment Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Pediatric Psoriasis Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Pediatric Psoriasis Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Pediatric Psoriasis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Pediatric Psoriasis Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Pediatric Psoriasis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Pediatric Psoriasis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Pediatric Psoriasis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Pediatric Psoriasis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Pediatric Psoriasis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Pediatric Psoriasis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Pediatric Psoriasis Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Pediatric Psoriasis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Pediatric Psoriasis Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Pediatric Psoriasis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Pediatric Psoriasis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Pediatric Psoriasis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Pediatric Psoriasis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Pediatric Psoriasis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Pediatric Psoriasis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 54. China Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Pediatric Psoriasis Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Pediatric Psoriasis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Pediatric Psoriasis Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Pediatric Psoriasis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Pediatric Psoriasis Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Pediatric Psoriasis Treatment Market Drivers
Figure 75. Pediatric Psoriasis Treatment Market Restraints
Figure 76. Pediatric Psoriasis Treatment Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Pediatric Psoriasis Treatment in 2022
Figure 79. Manufacturing Process Analysis of Pediatric Psoriasis Treatment
Figure 80. Pediatric Psoriasis Treatment Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source